Friday 6 November 2026
Export MET’s income statement to Excel — free account
MetLife, Inc.
MetLife, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $77.1 billion, up 8.59% from fiscal 2024.
- Revenue
- +18.2%
- EPS
- +200.8%
- Free cash flow
- −43.9%
- Total debt
- −1.97%
Quarter to September 2026, against a year earlier
98.27
1.48
−1.48%
Follow MET
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 7 | 7 | 8 |
| 11.26% | 12.41% | 12.36% | 17.04% | ||
| 0.45% | 0.48% | 0.47% | 0.69% | ||
ROIC |
11.21% | 11.94% | 10.65% | 14.46% | |
Return on Tangible Assets |
(0.79%) | (0.85%) | (0.84%) | (1.24%) | |
Average Days of Receivables |
235.42 | 238.93 | 234.72 | 179.94 | |
Free Cash Flow per Share |
25.55 | 23.80 | 24.21 | 0.00 | |
Free Cash Flow |
17,092.00 | 15,517.00 | 15,558.00 | 13,991.00 | |
| Other line items | |||||
Cash ROIC |
24.40% | 21.99% | 23.16% | 20.20% | |
Accounts Receivable Turnover |
1.93 | 1.88 | 1.91 | 2.03 | |
Accounts Payable Turnover |
0.26 | 0.26 | 0.27 | 0.27 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
1,440.32 | 1,432.19 | 1,399.06 | 1,342.04 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.27) | (0.25) | (0.25) | (0.22) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.74% | 2.79% | 2.80% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
4.39 | 4.51 | 4.46 | — | |
Operating CF/Net income |
5.39 | 4.52 | 4.52 | 2.81 | |
Depreciation/Fixed assets |
0.00 | — | — | — | |
Capex/Depreciation |
0.00 | — | — | — | |
Revenue per Share |
115.24 | 119.00 | 123.57 | 0.00 | |
Operating CF per Share |
25.55 | 23.80 | 24.21 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 6 Nov 2026